JAMA Article on the Link Between AntiDepressants during pregnancy and Autism
The Journal of the American Medical Association, (JAMA) released the results of a study which shows a link between the use of anti-depressants, specifically selective serotonin reuptake inhibitors (SSRI’s) and autism spectrum disorder, ASD.
The study which was conducted in Quebec and reported in this month’s edition of JAMA concludes:
Use of antidepressants, specifically selective serotonin reuptake inhibitors, during the second and/or third trimester increases the risk of ASD in children, even after considering maternal depression
There has been an ongoing debate among doctors about whether or not the use of antidepressants during pregnancy could have adverse consequences for the baby. This most recent study which looked more than 145,000 infants, found that there was such a link.
Although more study is needed, the potential association between antidepressants in the second and third trimester of pregnancy and Autism Spectrum Disorder should prompt an in depth discussion between pregnant moms and their OB-Gyns about the use of antidepressants during pregnancy.